Effect of the Sources and Passage Numbers on Efficacy of Mesenchymal Stem Cells Transplants in the R6/2 Mouse Model of Huntington's Disease

被引：0
|
作者：
Rossignol, J. [1 ,2 ]
Fink, K. D. [1 ]
Hisscock, N. L. [1 ]
Bavar, A. M. [1 ]
Crane, A. T. [1 ]
Lescaudron, L. [3 ,4 ]
Dunbar, G. L. [1 ,2 ]
机构：
[1] Field Neurosci Inst, Saginaw, MI USA
[2] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA
[3] CHU Hotel Dieu, ITUN, INSERM, U643, Nantes, France
[4] Univ Nantes, Fac Sci & Tech, Nantes, France
来源：
CELL TRANSPLANTATION | 2011年 / 20卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [21] Localization of neuroglobin in the brain of R6/2 mouse model of Huntington's disease
    Cardinale, A.
    Fusco, F. R.
    Paldino, E.
    Giampa, C.
    Marino, M.
    Nuzzo, M. T.
    D'Angelo, V.
    Laurenti, D.
    Straccia, G.
    Fasano, D.
    Sarnataro, D.
    Squillaro, T.
    Paladino, S.
    Melone, Mariarosa A. B.
    NEUROLOGICAL SCIENCES, 2018, 39 (02) : 275 - 285
  • [22] Quantification of Huntington's Disease Related Markers in the R6/2 Mouse Model
    Etxeberria-Rekalde, Estibaliz
    Alzola-Aldamizetxebarria, Saioa
    Flunkert, Stefanie
    Hable, Isabella
    Daurer, Magdalena
    Neddens, Joerg
    Hutter-Paier, Birgit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 13
  • [23] Social Behaviour is Impaired in the R6/2 Mouse Model of Huntington's Disease
    Wood, Nigel I.
    Morton, A. Jennifer
    JOURNAL OF HUNTINGTONS DISEASE, 2015, 4 (01) : 61 - 73
  • [24] Impaired glial metabolism in R6/2 mouse model of Huntington's disease
    Andersen, J.
    Skotte, N.
    Norremolle, A.
    Waagepetersen, H. S.
    GLIA, 2017, 65 : E166 - E166
  • [25] Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease
    Papalexi, E
    Persson, A
    Björkqvist, M
    Petersén, Å
    Woodman, B
    Bates, GP
    Sundler, F
    Mulder, H
    Brundin, P
    Popovic, N
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (06) : 1541 - 1546
  • [26] Hair dysmorphology in the R6/1 and R6/2 mouse models of Huntington's disease
    Pierzynowska, Karolina
    Podlacha, Magdalena
    Luszczek, Dorota
    Rintz, Estera
    Gaffke, Lidia
    Szczudlo, Zuzanna
    Tomczyk, Marta
    Smolenski, Ryszard T.
    Wegrzyn, Grzegorz
    GENE, 2021, 765
  • [27] Extracts of Adipose Derived Stem Cells Slows Progression in the R6/2 Model of Huntington's Disease
    Im, Wooseok
    Ban, Jaejun
    Lim, Jiyeon
    Lee, Mijung
    Lee, Soon-Tae
    Chu, Kon
    Kim, Manho
    PLOS ONE, 2013, 8 (04):
  • [28] Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease
    Yu-Taeger, Libo
    Stricker-Shaver, Janice
    Arnold, Katrin
    Bambynek-Dziuk, Patrycja
    Novati, Arianna
    Singer, Elisabeth
    Lourhmati, Ali
    Fabian, Claire
    Magg, Janine
    Riess, Olaf
    Schwab, Matthias
    Stolzing, Alexandra
    Danielyan, Lusine
    Nguyen, Hoa Huu Phuc
    CELLS, 2019, 8 (06)
  • [29] INTRANASAL ADMINISTRATION OF MESENCHYMAL STEM CELLS AMELIORATES THE ABNORMAL DOPAMINE TRANSMISSION SYSTEM AND INFLAMMATORY REACTION IN THE R6/2 MOUSE MODEL OF HUNTINGTON DISEASE
    Yu-Taeger, Libo
    Stricker-Shaver, Janice
    Arnold, Katrin
    Bambynek-Dziuk, Patrycja
    Novati, Arianna
    Singer, Elisabeth
    Claire, Fabian
    Magg, Janine
    Riess, Olaf
    Stolzing, Alexandra
    Danielyan, Lusine
    Hoa Phuc Nguyen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A96 - A96
  • [30] Efficacy of therapy by MK-28 PERK activation in the Huntington's disease R6/2 mouse model
    Shacham, Talya
    Offen, Daniel
    Lederkremer, Gerardo Z.
    NEUROTHERAPEUTICS, 2024, 21 (02)
12345